Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and Endari®

Provided By PR Newswire

Last update: Sep 28, 2022

Nationally Syndicated Radio Programming Will Educate and Support SCD Patients

TORRANCE, Calif., Sept. 28, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. ( OTCQX: EMMA) a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced a collaboration with the Steve Harvey Morning Show cast member Kier (Junior) Spates to share Mr. Spates' personal experience with the use of Endari®, Emmaus' prescription L-glutamine oral powder, to treat his sickle cell disease, or SCD.